Page last updated: 2024-08-18

pyrroles and Fallopian Tube Neoplasms

pyrroles has been researched along with Fallopian Tube Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berlin, S; Campos, SM; Horowitz, NS; Matulonis, U; Penson, RT; Pereira, L; Roche, M; Szymonifka, J; Tyburski, K; Whalen, C	1

Trials

1 trial(s) available for pyrroles and Fallopian Tube Neoplasms

Article	Year
A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma. Gynecologic oncology, 2013, Volume: 128, Issue:2 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Disease-Free Survival; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Humans; Indoles; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib	2013

Article

Year

A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma.

Gynecologic oncology, 2013, Volume: 128, Issue:2

Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Disease-Free Survival; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Humans; Indoles; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib

2013